PL380611A1 - Postępowanie z zaburzeniami oftalmologicznymi, włącznie ze zwyrodnieniem plamki - Google Patents
Postępowanie z zaburzeniami oftalmologicznymi, włącznie ze zwyrodnieniem plamkiInfo
- Publication number
- PL380611A1 PL380611A1 PL380611A PL38061105A PL380611A1 PL 380611 A1 PL380611 A1 PL 380611A1 PL 380611 A PL380611 A PL 380611A PL 38061105 A PL38061105 A PL 38061105A PL 380611 A1 PL380611 A1 PL 380611A1
- Authority
- PL
- Poland
- Prior art keywords
- management
- macular degeneration
- including macular
- ophthalmologic disorders
- ophthalmologic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/25—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
- C07C211/48—N-alkylated amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
- C07C217/86—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/10—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/28—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to an acyclic carbon atom of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/40—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/15—Unsaturated ethers containing only non-aromatic carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/203—Unsaturated compounds containing keto groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54545604P | 2004-02-17 | 2004-02-17 | |
US56760404P | 2004-05-03 | 2004-05-03 | |
US57832404P | 2004-06-09 | 2004-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL380611A1 true PL380611A1 (pl) | 2007-02-19 |
Family
ID=34891141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL380611A PL380611A1 (pl) | 2004-02-17 | 2005-02-17 | Postępowanie z zaburzeniami oftalmologicznymi, włącznie ze zwyrodnieniem plamki |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080176952A1 (pl) |
EP (1) | EP1722766A2 (pl) |
KR (1) | KR20060135819A (pl) |
AU (1) | AU2005215778B2 (pl) |
BR (1) | BRPI0507807A (pl) |
CA (1) | CA2555261A1 (pl) |
IL (1) | IL177284A0 (pl) |
IS (1) | IS8530A (pl) |
MX (1) | MXPA06008780A (pl) |
NO (1) | NO20064181L (pl) |
PL (1) | PL380611A1 (pl) |
RU (1) | RU2006133300A (pl) |
WO (1) | WO2005079774A2 (pl) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2324823A3 (en) | 2003-03-14 | 2011-11-16 | University of Washington | Retinoid replacements and opsin agonists and methods for the use thereof |
HUE036596T2 (hu) | 2004-06-18 | 2018-07-30 | Univ Washington | Retinaszármazékok és módszerek ezek felhasználására látászavarok kezeléséhez |
EP2277516A1 (en) | 2004-06-23 | 2011-01-26 | ReVision Therapeutics, Inc. | Retinyl derivatives for treating ophtalmic conditions |
AU2005287343A1 (en) * | 2004-08-18 | 2006-03-30 | Sirion Therapeutics, Inc. | Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders |
EP1807103A4 (en) * | 2004-11-04 | 2009-02-11 | Sirion Therapeutics Inc | MODULATORS OF A COMPLEX RETINOL-RETINOL-BINDING PROTEIN-TRANSTHYRETINE FORMATION |
WO2006091761A1 (en) * | 2005-02-24 | 2006-08-31 | University Of Washington | Methods for treatment of retinal degenerative disease |
JP5042215B2 (ja) * | 2005-05-26 | 2012-10-03 | ニューロン システムズ, インコーポレイテッド | 網膜疾患を処置するための組成物および方法 |
GB2426450A (en) * | 2005-06-06 | 2006-11-29 | Sytera Inc | Methods and compositions for treating ophthalmic conditions with retinyl derivatives |
UA81382C2 (en) * | 2005-07-11 | 2007-12-25 | Composition for treating retinol-related diseases by modulation of retinol binding | |
US20090170841A1 (en) | 2007-04-20 | 2009-07-02 | Acucela Inc. | Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders |
US20100227811A1 (en) * | 2007-05-14 | 2010-09-09 | University Of South Florida | Farnesylamine derivatives and methods of use |
BRPI0908154A2 (pt) * | 2008-02-11 | 2015-08-11 | Univ Washington | Métodos para o tratamento e a prevenção de disfunções retinianas relacionadas à idade |
JP5663025B2 (ja) | 2009-09-15 | 2015-02-04 | キューエルティー インコーポレイテッド | 9−cis−レチニルエステルを脂質ビヒクル中に含む医薬製剤 |
EP2509596B1 (en) | 2009-12-08 | 2019-08-28 | Case Western Reserve University | Gamma aminoacids for treating ocular disorders |
CA2782015C (en) | 2009-12-11 | 2020-08-25 | Neuron Systems, Inc. | Topical ophthalmic compositions and methods for the treatment of macular degeneration |
RU2622763C2 (ru) | 2010-04-19 | 2017-06-19 | Новелион Терапьютикс Инк. | Лечебная схема и способы лечения или уменьшения нарушений зрения, связанных с дефицитом эндогенных ретиноидов |
WO2012078525A2 (en) * | 2010-12-06 | 2012-06-14 | Revision Therapeutics, Inc. | Compositions and methods for treating ophthalmic conditions |
WO2013134867A1 (en) | 2012-03-01 | 2013-09-19 | Qlt Inc. | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
RU2015120478A (ru) | 2012-12-20 | 2017-01-25 | Альдейра Терапьютикс, Инк. | Пери-карбинолы |
KR102243169B1 (ko) | 2013-01-23 | 2021-04-22 | 알데이라 테라퓨틱스, 아이엔씨. | 독성 알데히드 관련된 질병 및 치료 |
CN105228989A (zh) | 2013-01-25 | 2016-01-06 | 奥尔德拉医疗公司 | 黄斑变性治疗中的新颖捕获剂 |
EP3337486B1 (en) | 2015-08-21 | 2024-04-03 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
AU2017264697A1 (en) | 2016-05-09 | 2018-11-22 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
WO2018170476A1 (en) | 2017-03-16 | 2018-09-20 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
US11148998B2 (en) | 2017-05-23 | 2021-10-19 | The Regents Of The University Of Michigan | Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof |
EP3694500A4 (en) | 2017-10-10 | 2021-06-30 | Aldeyra Therapeutics, Inc. | TREATMENT OF INFLAMMATORY DISORDERS |
JP2021533154A (ja) | 2018-08-06 | 2021-12-02 | アルデイラ セラピューティクス, インコーポレイテッド | 多形化合物およびその使用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2654722A (en) * | 1950-09-16 | 1953-10-06 | Standard Oil Dev Co | Stabilized solid organic compositions containing acyl-p-aminophenols |
US3780103A (en) * | 1967-03-30 | 1973-12-18 | Ciba Geigy Corp | Alkylhydroxybenzylamides |
ZA6808345B (en) * | 1967-12-22 | May & Baker Ltd | Benzene derivatives | |
US4215215A (en) * | 1975-08-01 | 1980-07-29 | Hoffmann-La Roche Inc. | 9-Phenyl-nonate traene compounds |
US4108880A (en) * | 1975-11-03 | 1978-08-22 | Johnson & Johnson | Esters of retinoic acid |
US4310546A (en) * | 1978-07-31 | 1982-01-12 | Johnson & Johnson | Novel retinoids and their use in preventing carcinogenesis |
US4742400A (en) * | 1986-02-12 | 1988-05-03 | Ricoh Corporation | Digital image processing device for intermediate tone |
US4743400A (en) * | 1986-09-22 | 1988-05-10 | Mcneilab, Inc. | Process for preparing retinoyl chlorides |
US5824685A (en) * | 1995-02-01 | 1998-10-20 | The Johns Hopkins University School Of Medicine | Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
US5661138A (en) * | 1996-10-03 | 1997-08-26 | Clarion Pharmaceutical, Inc. | (o-Acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines |
JP3972159B2 (ja) * | 1998-05-12 | 2007-09-05 | グンゼ株式会社 | 蒸着バルーン用フィルム |
EP1259470A4 (en) * | 2000-02-07 | 2005-06-15 | Zhenhua Yang | GROUP OF AGGREGATES COMPRISING EFFECTIVE COMPOUNDS WITH SPECIFIC STRUCTURE AND METHOD FOR THE PRODUCTION THEREOF |
US20030032078A1 (en) * | 2001-01-23 | 2003-02-13 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of macular and retinal degenerations |
ES2302770T3 (es) * | 2002-04-17 | 2008-08-01 | Cognis Ip Management Gmbh | Mezcla de sustancias activas de extractos del genero vaccinium y compuestos de caroteno. |
EP2324823A3 (en) * | 2003-03-14 | 2011-11-16 | University of Washington | Retinoid replacements and opsin agonists and methods for the use thereof |
EP2277516A1 (en) | 2004-06-23 | 2011-01-26 | ReVision Therapeutics, Inc. | Retinyl derivatives for treating ophtalmic conditions |
WO2006047475A2 (en) * | 2004-10-25 | 2006-05-04 | Sytera, Inc. | Detection and analysis of ophthalmically-relevant fluorescent molecules |
JP4178281B2 (ja) * | 2004-12-08 | 2008-11-12 | シリオン セラピューティクス, インコーポレイテッド | レチノール関連疾患を処置するための方法、アッセイおよび組成物 |
-
2005
- 2005-02-17 WO PCT/US2005/004990 patent/WO2005079774A2/en active Application Filing
- 2005-02-17 US US10/598,048 patent/US20080176952A1/en not_active Abandoned
- 2005-02-17 KR KR1020067019039A patent/KR20060135819A/ko not_active Application Discontinuation
- 2005-02-17 PL PL380611A patent/PL380611A1/pl unknown
- 2005-02-17 CA CA002555261A patent/CA2555261A1/en not_active Abandoned
- 2005-02-17 EP EP05723179A patent/EP1722766A2/en not_active Withdrawn
- 2005-02-17 MX MXPA06008780A patent/MXPA06008780A/es not_active Application Discontinuation
- 2005-02-17 BR BRPI0507807-5A patent/BRPI0507807A/pt not_active IP Right Cessation
- 2005-02-17 AU AU2005215778A patent/AU2005215778B2/en not_active Ceased
- 2005-02-17 RU RU2006133300/04A patent/RU2006133300A/ru not_active Application Discontinuation
-
2006
- 2006-08-03 IL IL177284A patent/IL177284A0/en unknown
- 2006-08-10 IS IS8530A patent/IS8530A/is unknown
- 2006-09-15 NO NO20064181A patent/NO20064181L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1722766A2 (en) | 2006-11-22 |
CA2555261A1 (en) | 2005-09-01 |
KR20060135819A (ko) | 2006-12-29 |
AU2005215778B2 (en) | 2009-03-12 |
AU2005215778A1 (en) | 2005-09-01 |
IL177284A0 (en) | 2006-12-10 |
US20080176952A1 (en) | 2008-07-24 |
WO2005079774A2 (en) | 2005-09-01 |
NO20064181L (no) | 2006-11-14 |
RU2006133300A (ru) | 2008-03-27 |
MXPA06008780A (es) | 2007-02-16 |
WO2005079774A3 (en) | 2006-03-02 |
BRPI0507807A (pt) | 2007-07-31 |
IS8530A (is) | 2006-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL177284A0 (en) | Management of ophthalmologic disorders, including macular degeneration | |
WO2007018797A8 (en) | Selective nerve stimulation for the treatment of eating disorders | |
AP2378A (en) | Sulfonamide derivatives for the treatment of diseases. | |
AP2359A (en) | Sulfonamide derivatives for the treatment of diseases. | |
EP1732484A4 (en) | OPHTHALMIC IMPLANT FOR THE TREATMENT OF GLAUCOMA | |
IL191283A (en) | Compositions for treating eye irregularities | |
EP1874234A4 (en) | ARTIFICIAL HORN SKIN | |
EP1893216A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES | |
IL180342A0 (en) | Compositions and methods for treating eye disorders and conditions | |
IL181069A0 (en) | Sulphonamide derivatives , their preparation and their therapeutic application | |
ZA200706622B (en) | Microimplants for ocular administration | |
WO2010048332A3 (en) | Compounds for treating ophthalmic diseases and disorders | |
EP1833467A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR SLEEP DISORDERS | |
PL1888548T3 (pl) | Pochodna chinoliny do leczenia schorzeń siatkówki | |
GB201111329D0 (en) | Synthetic cornea from retinal stem cells | |
EP1814535A4 (en) | NITROSED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING EYE DISEASES | |
IL184314A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
WO2006135694A3 (en) | Uii-modulating compounds and their use | |
ZA200803445B (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof | |
EP1768656A4 (en) | TREATMENT OF OCULAR DISEASES | |
EP2083841A4 (en) | TREATMENT OF MACULAR DEGENERATION FROM AGING AND OTHER OCULAR DISEASES | |
EP1804646A4 (en) | CORNEAL BIOMETRY | |
GB0414772D0 (en) | Ophthalmic eye preparation | |
WO2007056500A3 (en) | Compounds with activity at estrogen receptors | |
ZA200607713B (en) | Management of opthalmologic disorders, including macular degeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |